Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
TAGRISSO™ (osimertinib) receives positive CHMP opinion for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
-
CHMP issues positive opinion on lesinurad for Gout
-
Durvalumab ATLANTIC trial supports clinical activity and AstraZeneca’s overall immuno-oncology strategy
-
AstraZeneca completes acquisition of ZS Pharma
-
AstraZeneca enhances long-term growth through Oncology investment in Acerta Pharma
-
AstraZeneca to strengthen therapy area franchise through acquisition of Takeda’s respiratory business
-
AstraZeneca continues strategic investment in China to accelerate delivery of innovative biologics and targeted medicines
-
AstraZeneca completes agreement with Perrigo for rights to Entocort® in the US
-
Discussions with Acerta Pharma BV
-
AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new Wallenberg Centre for Protein Research
Latest articles and press releases
All of our latest press releases and articles are available to explore
